Heier Jeffrey S. Insider Trading Activity

Average Profitability
22.62%
Insider Buys Quantity
2
Insider Buys Sum
$244,950.00
Insider Sells Quantity
2
Insider Sells Sum
$47,590.55

Insider Activity of Heier Jeffrey S.

According to the SEC Form 4 filings, Heier Jeffrey S., being in a position of

  1. Chief Scientific Officer at Ocular Therapeutix, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23709 shares for $203,984,
    over all time since 2019-03-15, has bought 63000 shares for $244,950, and sold 46307 shares for $426,107.

Biography of Heier Jeffrey S.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $203,9845100

Comparison of Insiders on Amount of Buys and Sells

2026-10-02SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
10,869
0.0049%
$7.05$76,626+1.8%
2026-08-24SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,296
0.0015%
$10.78$35,531-28.9%
2026-05-26SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,018
0.0013%
$8.20$24,748+9.53%
2026-02-23SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,057
0.0014%
$8.28$25,312+7.97%
2025-11-24SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,469
0.002%
$12.04$41,767-22.07%
2025-10-02SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
10,502
0.0057%
$11.04$115,942-10.76%
2025-08-25SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,063
0.0017%
$12.04$36,879-14.91%
2025-05-23SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,024
0.0019%
$7.18$21,712+51.58%
2025-02-24SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
3,061
0.0019%
$6.87$21,029+64.34%
2024-11-25SaleOcular Therapeutix, Inc.
OCUL
Chief Scientific Officer
2,948
0.0019%
$9.01$26,561-1.76%
2022-05-12PurchaseOcular Therapeutix, Inc.
OCUL
15,000
0.0198%
$3.05$45,750+42.52%
2019-03-15PurchaseOcular Therapeutix, Inc.
OCUL
director
48,000
0.1164%
$4.15$199,200+2.72%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.